Named on one round in the feed.
Since 2026-11-10
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
PsiThera A biotechnology company harnessing biologically relevant protein states and physical artificial intelligence to create oral drugs for immune and inflammatory diseases | Funding round Verified against 1 source | $25M | 2026-11-10 | [ PART ] |